# A Study to Examine the Effects of Telaprevir on the Pharmacokinetics of Cyclosporine and Tacrolimus in Healthy Adults

> **NCT01038167** · PHASE1 · COMPLETED · sponsor: **Vertex Pharmaceuticals Incorporated** · enrollment: 20 (estimated)

## Conditions studied

- Hepatitis C

## Interventions

- **DRUG:** telaprevir
- **DRUG:** telaprevir
- **DRUG:** cyclosporine
- **DRUG:** cyclosporine
- **DRUG:** tacrolimus
- **DRUG:** tacrolimus

## Key facts

- **NCT ID:** NCT01038167
- **Lead sponsor:** Vertex Pharmaceuticals Incorporated
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-01
- **Primary completion:** 2010-04
- **Final completion:** 2010-04
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2010-04-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01038167

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01038167, "A Study to Examine the Effects of Telaprevir on the Pharmacokinetics of Cyclosporine and Tacrolimus in Healthy Adults". Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/clinical/NCT01038167. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*